| Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 219 :715 , 2012 |
| Abstract : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| ESTHER : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedID: 21748252 |
Apostol G, Abi-Saab WM, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD (2012)
Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Psychopharmacology (Berl)
219 :715
Apostol G, Abi-Saab WM, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD (2012)
Psychopharmacology (Berl)
219 :715